anh-usa

While the FRESH Act promises GRAS reform, a closer look reveals a shift toward burdensome FDA gatekeeping that could restrict access to safe, natural ingredients. Action Alert!

Listen to the audio ...

The FDA is signaling a narrower definition of “dietary supplement” that could sideline innovative natural products and limit consumer choice—unless it’s challenged.

Listen to the audio version of this article:

THE TOPLINE

The FDA is considering a narrow interpretation of “dietary substance” that could ex...

A federal court dismissed ANH’s homeopathy lawsuit on procedural grounds—so we’re taking the fight directly back to the FDA.

Listen to the audio version of this article:

THE TOPLINE

The court did not rule on the merits, dismissing the case instead for lack of standing. This leaves unresolved the core ...

A seemingly simple supplement registry could quietly reshape the entire natural health market—and limit what consumers can access. Action Alert!

Listen to the audio version of this article:

...

The current leadership of FDA may be softening its stance on peptides—but past patterns suggest the outcome is far from certain. Action Alert!

Listen to the audio version of this article:

...